New Launch Site Discount — 40% off sitewide · +10% with Bank Pay · New customers stack 40% off
1 / 6
Myogenic Peptides · Performance & Recovery Research
IGF-1 LR3
$40.00$24.00Save 40%
Low stock
99% Pure | USA Finish | Multi Dose | Finished in the USA
IGF-1 LR3 is a long-acting analog of insulin-like growth factor-1 (IGF-1) engineered for extended receptor binding and enhanced bioactivity. Ideal for labs probing cell proliferation, protein synthesis, and metabolic regulation, IGF-1 LR3 delivers sustained IGF-1 receptor activation in both cell-culture and small-animal models.
For Research Use Only. Not for human consumption or therapeutic treatment.
99% Pure | USA Finish | Multi Dose | Finished in the USA
IGF-1 LR3 is a long-acting analog of insulin-like growth factor-1 (IGF-1) engineered for extended receptor binding and enhanced bioactivity. Ideal for labs probing cell proliferation, protein synthesis, and metabolic regulation, IGF-1 LR3 delivers sustained IGF-1 receptor activation in both cell-culture and small-animal models. Each 1 mg vial is HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg), ensuring reproducible, high-precision data for your IGF-1 research.
What Is IGF-1 LR3 Peptide?
IGF-1 LR3 is a synthetic analog of human insulin-like growth factor-1 in which the first three amino acids are removed and an arginine added at position 3. This modification greatly extends its half-life and receptor affinity. In research settings, IGF-1 LR3 is used to examine IGF-1 receptor dynamics, anabolic signaling, and metabolic regulation with greater temporal control than native IGF-1.
Why Choose IGF-1 LR3?
Researchers select IGF-1 LR3 when they require prolonged and potent IGF-1 activity without rapid degradation. Its enhanced stability and high receptor affinity produce consistent activation of downstream pathways—mTOR, MAPK, and PI3K/Akt—critical for studies of cell proliferation, protein synthesis, and glucose metabolism. Manufactured and verified to ≥ 99% purity, IGF-1 LR3 ensures rigorous reproducibility across both in vitro and in vivo protocols.
What Sets IGF-1 LR3 Apart?
Unlike native IGF-1, IGF-1 LR3’s structural tweaks confer a three- to five-fold longer half-life and increased receptor binding, making it uniquely suited for sustained signaling experiments. Its ability to maintain elevated IGF-1 levels for over 24 hours in animal models eliminates the need for multiple daily doses, simplifying study design and reducing variability. This precision makes IGF-1 LR3 the go-to reagent for high-impact anabolic and metabolic-pathway research.
Research observations
01
Extended IGF-1 Receptor Activation
IGF-1 LR3’s modified structure prolongs receptor binding, enabling sustained signaling windows in proliferation assays.
02
Cell-Growth & Proliferation Modeling
Drives robust increases in cell-cycle markers (Cyclin D1, PCNA) in fibroblast and myoblast cultures.
03
Protein-Synthesis Enhancement
Protein-Synthesis Enhancement
04
Metabolic-Pathway Insights
Modulates glucose-uptake and lipid-metabolism genes (GLUT4, PPARγ) in adipocyte and hepatocyte models.
05
Straightforward Prep & Storage
Reconstitute in sterile or bacteriostatic water; store lyophilized at – 20 °C and solution at 2–8 °C for up to 7 days.
06
In Vivo Pharmacodynamics
In rodent dosing, IGF-1 LR3 yields prolonged IGF-1 plasma levels (≥ 24 h), ideal for long-term signaling studies.
1 / 6
